Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum NuCana PLC NCNA

Healthcare Biotechnology
NuCana plc is a United Kingdom-based clinical-stage biopharmaceutical company. The Company is focused on developing treatment outcomes for patients with cancer by applying its ProTide technology. The Company's pipeline includes NUC-3373, and NUC-7738. NUC-3373 is a ProTide transformation of the active anti-cancer metabolite of 5-fluorouracil (5-FU). 5-FU is a prescribed anti-cancer agent. NUC... see more

Bullboard (NDAQ:NCNA)

View:
Post by whytestockson Nov 11, 2024 4:02pm

NuCana Announces Encouraging Initial Data from Phase 1b/2 Mo

Just In: $NCNA NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or DocetaxelPatients with Advanced Solid Tumors who had Exhausted ...more  
36
Post by whytestockson Sep 25, 2024 8:32pm

NuCana Announces Grant of Composition-of-Matter Patent for N

BREAKING NEWS: $NCNA NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United StatesEDINBURGH, United Kingdom, Sept. 25, 2024 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ ...more  
27
Post by 10QKingon Aug 19, 2024 1:36pm

NCNA Upgrade out with 150$ Price Target Low Float 4$

NCNA Upgrade out with 150$ price target Currently 4$ Low Float Phase 2 Data due soon https://www.investing.com/news/company-news/nucana-shares-receive-150-stock-pt-at-oppenheimer-on-upbeat-trial ...more  
91
Post by whytestockson Apr 16, 2024 10:15am

US Companies Moving the Markets, Morning edition
Tue, Ap

Just In: $NCNA US Companies Moving the Markets, Morning edition Tue, Apr 16, 2024 as of 10.00 am ETA look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) rose 37.1% to $0 ...more  
43
Post by whytestockson Apr 16, 2024 10:00am

NuCana Announces Completion of ADS Ratio Change

NEWS: $NCNA NuCana Announces Completion of ADS Ratio ChangeEDINBURGH, United Kingdom, April 16, 2024 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced that the Company@s previously disclosed ...more  
41
Post by Iseneschalon Mar 13, 2024 9:00am

NCNA.....day 2 of volume and Price Action

On watch....no News Release No positon
46
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities